Darlene Staines

Teva And Fosun Partner To Develop A Novel Immunotherapy Targeting Melanoma And Other Cancers

Regeneron Awarded $407 Million In Amgen Antitrust Suit

FDA Approves Biocon Biologics' Bevacizumab Biosimilar

FDA To Phase Out Animal Testing For Monoclonal Antibodies And Other Drugs

Teva And Samsung Bioepis Announce U.S. Launch Of EPYSQLI® (Eculizumab-aagh), A SOLIRIS® Biosimilar

Amgen Files Three IPR Petitions Challenging Bristol-Myers Squibb Anti-PD1 And Anti-CTLA-4 Antibody Combination Method Of Treatment Patents

Amgen And Celltrion Settle Denosumab BPCIA Case